Melanoma

Epidemiology, Diagnosis, Treatment, and Outcomes

William Tuong, Lily S. Cheng, April W. Armstrong

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Melanoma is a skin cancer that arises from the malignant transformation of melanocytes. Although it is typically considered a pigmented lesion, the clinical presentation of melanoma can vary greatly. With increased efforts in screening and detection of early-stage melanoma, researchers and clinicians hope to improve clinical outcomes for patients with melanoma. Novel immunotherapies directed at specific molecular targets in the pathogenesis of melanoma usher in a new era of treatment of advanced melanoma.

Original languageEnglish (US)
Pages (from-to)113-124
Number of pages12
JournalDermatologic Clinics
Volume30
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Melanoma
Epidemiology
Melanocytes
Skin Neoplasms
Immunotherapy
Research Personnel
Therapeutics

Keywords

  • Cause
  • Epidemiology
  • Melanoma
  • Prevention
  • Prognosis
  • Treatment

ASJC Scopus subject areas

  • Dermatology

Cite this

Melanoma : Epidemiology, Diagnosis, Treatment, and Outcomes. / Tuong, William; Cheng, Lily S.; Armstrong, April W.

In: Dermatologic Clinics, Vol. 30, No. 1, 01.2012, p. 113-124.

Research output: Contribution to journalArticle

Tuong, William ; Cheng, Lily S. ; Armstrong, April W. / Melanoma : Epidemiology, Diagnosis, Treatment, and Outcomes. In: Dermatologic Clinics. 2012 ; Vol. 30, No. 1. pp. 113-124.
@article{c3bd4f3402534404be102a91368d7d55,
title = "Melanoma: Epidemiology, Diagnosis, Treatment, and Outcomes",
abstract = "Melanoma is a skin cancer that arises from the malignant transformation of melanocytes. Although it is typically considered a pigmented lesion, the clinical presentation of melanoma can vary greatly. With increased efforts in screening and detection of early-stage melanoma, researchers and clinicians hope to improve clinical outcomes for patients with melanoma. Novel immunotherapies directed at specific molecular targets in the pathogenesis of melanoma usher in a new era of treatment of advanced melanoma.",
keywords = "Cause, Epidemiology, Melanoma, Prevention, Prognosis, Treatment",
author = "William Tuong and Cheng, {Lily S.} and Armstrong, {April W.}",
year = "2012",
month = "1",
doi = "10.1016/j.det.2011.08.006",
language = "English (US)",
volume = "30",
pages = "113--124",
journal = "Dermatologic Clinics",
issn = "0733-8635",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Melanoma

T2 - Epidemiology, Diagnosis, Treatment, and Outcomes

AU - Tuong, William

AU - Cheng, Lily S.

AU - Armstrong, April W.

PY - 2012/1

Y1 - 2012/1

N2 - Melanoma is a skin cancer that arises from the malignant transformation of melanocytes. Although it is typically considered a pigmented lesion, the clinical presentation of melanoma can vary greatly. With increased efforts in screening and detection of early-stage melanoma, researchers and clinicians hope to improve clinical outcomes for patients with melanoma. Novel immunotherapies directed at specific molecular targets in the pathogenesis of melanoma usher in a new era of treatment of advanced melanoma.

AB - Melanoma is a skin cancer that arises from the malignant transformation of melanocytes. Although it is typically considered a pigmented lesion, the clinical presentation of melanoma can vary greatly. With increased efforts in screening and detection of early-stage melanoma, researchers and clinicians hope to improve clinical outcomes for patients with melanoma. Novel immunotherapies directed at specific molecular targets in the pathogenesis of melanoma usher in a new era of treatment of advanced melanoma.

KW - Cause

KW - Epidemiology

KW - Melanoma

KW - Prevention

KW - Prognosis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=82455216803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455216803&partnerID=8YFLogxK

U2 - 10.1016/j.det.2011.08.006

DO - 10.1016/j.det.2011.08.006

M3 - Article

VL - 30

SP - 113

EP - 124

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 1

ER -